Estimated limits of IMRT dose escalation using varied planning target volume margins

Physics in Medicine and Biology

Volumn 53, Issue 14, 2008, Pages 3777-3788

  Goulet, Christopher C ^a   Herman, Michael G ^a   Hillman, David W ^a   Davis, Brian J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DATA SETS; DOSE ESCALATION; PLANNING TARGET VOLUME (PTV); PROSTATE CANCER (CAP);

LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLADDER; BRACHYTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER SYSTEM; GLEASON SCORE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RECTUM; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM;

EID: 47649105060     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/53/14/005     Document Type: Article

References (29)

1. 103palladium brachytherapy: the clinical research committee of the American Brachytherapy Society Int. J. Radiat. Oncol. Biol. Phys. 47 273-5
2. Burman C et al 1997 Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate Int. J. Radiat. Oncol. Biol. Phys. 39 863-73
3. Cheung P et al 2005 Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 62 418-25
4. Crook J, Esche B and Futter N 1996 Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective Urology 47 387-94
5. Hanks G E et al 1998 Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions Int. J. Radiat. Oncol. Biol. Phys. 41 501-10
6. Herman M G, Pisansky T M, Kruse J J, Prisciandaro J I, Davis B J and King B F 2003 Technical aspects of daily online positioning of the prostate for three-dimensional conformal radiotherapy using an electronic portal imaging device Int. J. Radiat. Oncol. Biol. Phys. 57 1131-40
7. Kucway R, Vicini F, Huang R, Stromberg J, Gonzalez J and Martinez A 2002 Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy J. Urol. 167 2443-7
8. Kupelian P et al 2005 Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995 Int. J. Radiat. Oncol. Biol. Phys. 61 415-9
9. Kupelian P A, Elshaikh M, Reddy C A, Zippe C and Klein E A 2002 Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy J. Clin. Oncol. 20 3376-85
10. Michalski J M et al 2000 Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406 Int. J. Radiat. Oncol. Biol. Phys. 46 391-402
11. Michalski J M et al 2002 Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406 Semin. Radiat. Oncol. 12 75-80
12. Michalski J M et al 2003 Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II Int. J. Radiat. Oncol. Biol. Phys. 56 192-8
13. Michalski J M et al 2004 Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV Int. J. Radiat. Oncol. Biol. Phys. 58 735-42
14. Nag S, Beyer D, Friedland J, Grimm P and Nath R 1999 American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 44 789-99
15. Neglia W J, Hussey D H and Johnson D E 1977 Megavoltage radiation therapy for carcinoma of the prostate Int. J. Radiat. Oncol. Biol. Phys. 2 873-83
16. Pinault S, Tetu B, Gagnon J, Monfette G, Dupont A and Labrie F 1992 Transrectal ultrasound evaluation of local prostate cancer in patients treated with LHRH agonist and in combination with flutamide Urology 39 254-61
17. Pollack A et al 2002 Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial Int. J. Radiat. Oncol. Biol. Phys. 53 1097-105
18. RTOG RTOG trial 9406 Available at http://www.rtog.org (accessed 1 January 2008)
19. Ryu J K et al 2002 Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy) Int. J. Radiat. Oncol. Biol. Phys. 54 1036-46
20. Schallenkamp J M, Herman M G, Kruse J J and Pisansky T M 2005 Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging Int. J. Radiat. Oncol. Biol. Phys. 63 800-11
21. Solhjem M C et al 2004 Prostate volume before and after permanent prostate brachytherapy in patients receiving neoadjuvant androgen suppression Cancer J. 10 343-8
22. Whittington R et al 1999 The effect of androgen deprivation on the early changes in prostate volume following transperineal ultrasound guided interstitial therapy for localized carcinoma of the prostate Int. J. Radiat. Oncol. Biol. Phys. 44 1107-10
23. Yang F E et al 1995 The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformal treatment planning for stage C prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 33 1009-17
24. Zelefsky M J et al 1999 Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma Cancer 85 2460-8
25. Zelefsky M J et al 2001 High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer J. Urol. 166 876-81
26. Zelefsky M J et al 2001 High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer J. Urol. 166 1839 (erratum)
27. Zelefsky M J et al 2002 High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients Int. J. Radiat. Oncol. Biol. Phys. 53 1111-6
28. Zelefsky M J and Harrison A 1997 Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: reducing the potential morbidity of therapy Urology 49 (Suppl.) 38-45
29. Zietman A L et al 2005 Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial JAMA 294 1233-9